Is level of exposure to a 12-step facilitation therapy associated with treatment outcome?

Elizabeth A. Wells, Dennis M. Donovan, Dennis C. Daley, Suzanne R. Doyle, Greg Brigham, Sharon B. Garrett, Michelle H. Ingalsbe, Mary A. Hatch-Maillette, Harold I. Perl, Robrina Walker

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

This study examined whether level of exposure to Stimulant Abuser Groups to Engage in 12-Step (STAGE-12), a 12-Step facilitative therapy, is related to treatment outcome. Data were from a large National Drug Abuse Treatment Clinical Trials Network (CTN) study comparing STAGE-12 combined with treatment-as-usual (TAU) to TAU alone. These analyses include only those randomized to STAGE-12 (n= 234). Assessments occurred at baseline and 30, 60, 90, and 180. days following randomization. High-exposure patients (n= 158; attended at least 2 of 3 individual, and 3 of 5 group, sessions), compared to those with less exposure (n= 76), demonstrated: (1) higher odds of self-reported abstinence from, and lower rates of, stimulant and non-stimulant drug use; (2) lower probabilities of stimulant-positive urines; (3) more days of attending and lower odds of not attending 12-Step meetings; (4) greater likelihood of reporting no drug problems; (5) more days of duties at meetings; and (6) more types of 12-Step activities. Many of these differences declined over time, but several were still significant by the last follow-up. Treatment and research implications are discussed.

Original languageEnglish (US)
Pages (from-to)265-274
Number of pages10
JournalJournal of Substance Abuse Treatment
Volume47
Issue number4
DOIs
StatePublished - 2014

Fingerprint

Therapeutics
Random Allocation
Pharmaceutical Preparations
Substance-Related Disorders
Clinical Trials
Urine
Research

Keywords

  • 12-Step
  • 12-Step facilitation
  • Cocaine
  • Intensive referral
  • Methamphetamine
  • Treatment exposure

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Clinical Psychology
  • Phychiatric Mental Health
  • Medicine (miscellaneous)
  • Medicine(all)

Cite this

Is level of exposure to a 12-step facilitation therapy associated with treatment outcome? / Wells, Elizabeth A.; Donovan, Dennis M.; Daley, Dennis C.; Doyle, Suzanne R.; Brigham, Greg; Garrett, Sharon B.; Ingalsbe, Michelle H.; Hatch-Maillette, Mary A.; Perl, Harold I.; Walker, Robrina.

In: Journal of Substance Abuse Treatment, Vol. 47, No. 4, 2014, p. 265-274.

Research output: Contribution to journalArticle

Wells, EA, Donovan, DM, Daley, DC, Doyle, SR, Brigham, G, Garrett, SB, Ingalsbe, MH, Hatch-Maillette, MA, Perl, HI & Walker, R 2014, 'Is level of exposure to a 12-step facilitation therapy associated with treatment outcome?', Journal of Substance Abuse Treatment, vol. 47, no. 4, pp. 265-274. https://doi.org/10.1016/j.jsat.2014.06.003
Wells, Elizabeth A. ; Donovan, Dennis M. ; Daley, Dennis C. ; Doyle, Suzanne R. ; Brigham, Greg ; Garrett, Sharon B. ; Ingalsbe, Michelle H. ; Hatch-Maillette, Mary A. ; Perl, Harold I. ; Walker, Robrina. / Is level of exposure to a 12-step facilitation therapy associated with treatment outcome?. In: Journal of Substance Abuse Treatment. 2014 ; Vol. 47, No. 4. pp. 265-274.
@article{95758cd9903e49888851f4df1d75a7de,
title = "Is level of exposure to a 12-step facilitation therapy associated with treatment outcome?",
abstract = "This study examined whether level of exposure to Stimulant Abuser Groups to Engage in 12-Step (STAGE-12), a 12-Step facilitative therapy, is related to treatment outcome. Data were from a large National Drug Abuse Treatment Clinical Trials Network (CTN) study comparing STAGE-12 combined with treatment-as-usual (TAU) to TAU alone. These analyses include only those randomized to STAGE-12 (n= 234). Assessments occurred at baseline and 30, 60, 90, and 180. days following randomization. High-exposure patients (n= 158; attended at least 2 of 3 individual, and 3 of 5 group, sessions), compared to those with less exposure (n= 76), demonstrated: (1) higher odds of self-reported abstinence from, and lower rates of, stimulant and non-stimulant drug use; (2) lower probabilities of stimulant-positive urines; (3) more days of attending and lower odds of not attending 12-Step meetings; (4) greater likelihood of reporting no drug problems; (5) more days of duties at meetings; and (6) more types of 12-Step activities. Many of these differences declined over time, but several were still significant by the last follow-up. Treatment and research implications are discussed.",
keywords = "12-Step, 12-Step facilitation, Cocaine, Intensive referral, Methamphetamine, Treatment exposure",
author = "Wells, {Elizabeth A.} and Donovan, {Dennis M.} and Daley, {Dennis C.} and Doyle, {Suzanne R.} and Greg Brigham and Garrett, {Sharon B.} and Ingalsbe, {Michelle H.} and Hatch-Maillette, {Mary A.} and Perl, {Harold I.} and Robrina Walker",
year = "2014",
doi = "10.1016/j.jsat.2014.06.003",
language = "English (US)",
volume = "47",
pages = "265--274",
journal = "Journal of Substance Abuse Treatment",
issn = "0740-5472",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Is level of exposure to a 12-step facilitation therapy associated with treatment outcome?

AU - Wells, Elizabeth A.

AU - Donovan, Dennis M.

AU - Daley, Dennis C.

AU - Doyle, Suzanne R.

AU - Brigham, Greg

AU - Garrett, Sharon B.

AU - Ingalsbe, Michelle H.

AU - Hatch-Maillette, Mary A.

AU - Perl, Harold I.

AU - Walker, Robrina

PY - 2014

Y1 - 2014

N2 - This study examined whether level of exposure to Stimulant Abuser Groups to Engage in 12-Step (STAGE-12), a 12-Step facilitative therapy, is related to treatment outcome. Data were from a large National Drug Abuse Treatment Clinical Trials Network (CTN) study comparing STAGE-12 combined with treatment-as-usual (TAU) to TAU alone. These analyses include only those randomized to STAGE-12 (n= 234). Assessments occurred at baseline and 30, 60, 90, and 180. days following randomization. High-exposure patients (n= 158; attended at least 2 of 3 individual, and 3 of 5 group, sessions), compared to those with less exposure (n= 76), demonstrated: (1) higher odds of self-reported abstinence from, and lower rates of, stimulant and non-stimulant drug use; (2) lower probabilities of stimulant-positive urines; (3) more days of attending and lower odds of not attending 12-Step meetings; (4) greater likelihood of reporting no drug problems; (5) more days of duties at meetings; and (6) more types of 12-Step activities. Many of these differences declined over time, but several were still significant by the last follow-up. Treatment and research implications are discussed.

AB - This study examined whether level of exposure to Stimulant Abuser Groups to Engage in 12-Step (STAGE-12), a 12-Step facilitative therapy, is related to treatment outcome. Data were from a large National Drug Abuse Treatment Clinical Trials Network (CTN) study comparing STAGE-12 combined with treatment-as-usual (TAU) to TAU alone. These analyses include only those randomized to STAGE-12 (n= 234). Assessments occurred at baseline and 30, 60, 90, and 180. days following randomization. High-exposure patients (n= 158; attended at least 2 of 3 individual, and 3 of 5 group, sessions), compared to those with less exposure (n= 76), demonstrated: (1) higher odds of self-reported abstinence from, and lower rates of, stimulant and non-stimulant drug use; (2) lower probabilities of stimulant-positive urines; (3) more days of attending and lower odds of not attending 12-Step meetings; (4) greater likelihood of reporting no drug problems; (5) more days of duties at meetings; and (6) more types of 12-Step activities. Many of these differences declined over time, but several were still significant by the last follow-up. Treatment and research implications are discussed.

KW - 12-Step

KW - 12-Step facilitation

KW - Cocaine

KW - Intensive referral

KW - Methamphetamine

KW - Treatment exposure

UR - http://www.scopus.com/inward/record.url?scp=84906064263&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84906064263&partnerID=8YFLogxK

U2 - 10.1016/j.jsat.2014.06.003

DO - 10.1016/j.jsat.2014.06.003

M3 - Article

C2 - 25064421

AN - SCOPUS:84906064263

VL - 47

SP - 265

EP - 274

JO - Journal of Substance Abuse Treatment

JF - Journal of Substance Abuse Treatment

SN - 0740-5472

IS - 4

ER -